PILOT TRIAL OF AN ADJUVANT PENTAVALENT VACCINE FOR PATIENTS WITH SMALL CELL LUNG CANCER (SCLC)

被引:0
|
作者
Krug, Lee M. [1 ]
Varghese, Anna [1 ]
Ragupathi, Govind [2 ]
George, Constantine [2 ]
Sawada, Ritsuko [3 ]
Scholz, Wolfgang W. [3 ]
Hansen, David [3 ]
Livingston, Philip O. [3 ]
Delasos, Lukas [1 ]
Pietanza, Maria C. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Thorac Oncol Serv, Dept Med, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY USA
[3] Mabvax Therapeut, San Diego, CA USA
关键词
small cell lung cancer; vaccine; immunotherapy;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P3.13-007
引用
收藏
页码:S1231 / S1232
页数:2
相关论文
共 50 条
  • [31] Overcoming acquired resistance to PD-1 inhibitor with the addition of metformin in small cell lung cancer (SCLC)
    Kim, Yeseul
    Vagia, Elena
    Viveiros, Pedro
    Kang, Cyra Y.
    Lee, Ju Young
    Gim, Gahyun
    Cho, Sukjoo
    Choi, Horyun
    Kim, Leeseul
    Park, Inae
    Choi, Jaeyoun
    Chae, Young Kwang
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (04) : 961 - 965
  • [32] Overcoming acquired resistance to PD-1 inhibitor with the addition of metformin in small cell lung cancer (SCLC)
    Yeseul Kim
    Elena Vagia
    Pedro Viveiros
    Cyra Y. Kang
    Ju Young Lee
    Gahyun Gim
    Sukjoo Cho
    Horyun Choi
    Leeseul Kim
    Inae Park
    Jaeyoun Choi
    Young Kwang Chae
    Cancer Immunology, Immunotherapy, 2021, 70 : 961 - 965
  • [33] First-line chemotherapy in metastatic small-cell lung cancer (SCLC)
    Wolf, M
    Tebbe, S
    Fink, T
    LUNG CANCER, 2004, 45 : S223 - S234
  • [34] RISK OF LATE RECURRENCE AND OR 2ND LUNG-CANCER AFTER TREATMENT OF PATIENTS WITH SMALL-CELL LUNG-CANCER (SCLC)
    SZCZEPEK, B
    SZYMANSKA, D
    DECKER, E
    WASOWSKA, H
    SLUPEK, A
    ROWINSKAZAKRZEWSKA, E
    LUNG CANCER, 1994, 11 (1-2) : 93 - 104
  • [35] Treatment and Outcomes of Patients with Limited-Stage Small-cell Lung Cancer in the Canadian SCLC Database (CASCADE)
    Moore, S. M.
    Zhan, L. J.
    Liu, G.
    Rittberg, R.
    Patel, D.
    Chowdhury, D.
    Leung, B.
    Cheng, S.
    Mckinnon, M.
    Khan, K.
    Snow, S.
    Fung, A. S.
    Dawe, D.
    Cheung, W. Y.
    Agulnik, J.
    Yan, M.
    Cohen, V.
    Wheatley-Price, P.
    Ho, C.
    Lok, B. H.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S542 - S542
  • [36] Validation of an algorithm able to differentiate small-cell lung cancer (SCLC) from non-small-cell lung cancer (NSCLC) patients by means of a tumour marker panel: Analysis of the errors
    Paone, G
    DeAngelis, G
    Portalone, L
    Greco, S
    Giosue, S
    Taglienti, A
    Bisetti, A
    Ameglio, F
    BRITISH JOURNAL OF CANCER, 1997, 75 (03) : 448 - 450
  • [37] P53 DENDRITIC CELL VACCINE IN SMALL CELL LUNG CANCER
    Chiappori, Alberto Alejandro
    Antonia, Scott
    Williams, Charles
    Pinder-Schenck, Mary
    Tanvetyanon, Tawee
    Gray, Jhanelle
    Haura, Eric
    Creelan, Ben
    Altiok, Soner
    Gonzalez-Vazquez, Germaine
    Chen, Dung-Tsa
    Gabrilovich, Dmitry
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (09) : S170 - S171
  • [38] Vaccine and immune cell therapy in non-small cell lung cancer
    Oliveres, Helena
    Caglevic, Christian
    Passiglia, Francesco
    Taverna, Simona
    Smits, Evelien
    Rolfo, Christian
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S1602 - S1614
  • [39] Racotumomab-alum vaccine for the treatment of non-small-cell lung cancer
    Maria Hernandez, Ana
    Maria Vazquez, Ana
    EXPERT REVIEW OF VACCINES, 2015, 14 (01) : 9 - 20
  • [40] THE ROLE OF SURGERY IN SMALL-CELL CARCINOMA OF THE LUNG (SCLC)
    HOLMES, EC
    LUNG CANCER, 1995, 12 : S17 - S21